The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K-Akt Pathways.

Candido S, Salemi R, Piccinin S, Falzone L, Libra M
Pharmaceutics. 2022 Mar 8;14(3). pii: pharmaceutics14030590. doi: 10.3390/pharmaceutics14030590. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.